amylin glp 1 dual agonist 📢 Beyond GLP-1: The next wave of incretin-based obesity treatments 🔹 GIP/ GLP-1 agonists (e.g., #Tirzepatide) ⤴️ weight loss vs. GLP-1 alone 🔸 Triple agonists (GIP/GLP-1/Glucagon) aim for >25% weight loss 🔹 Amycretin vs CagriSema: Unimolecular vs

Repeated treatment can divert money and time from therapies with stronger evidence

determine the effects and mechanism of flavonoid-enriched ethanolic extract of CBP on cataract prevention and treatment using a selenite cataract model

Oral administration also makes sense when shoulder issues accompany gut problems

Every batch of this product is tested for banned substances under a monitored program

"This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system."